Navigation Links
Hudson Valley Radiology Associates to Offer New Alzheimer's Disease Imaging Technique
Date:8/8/2012

NYACK, N.Y., Aug. 8, 2012 /PRNewswire/ -- Hudson Valley Radiology Associates (HVRA), a division of RadNet, Inc., a national market leader providing high-quality, cost-effective diagnostic imaging services through a network of 237 fully-owned and operated outpatient imaging centers, announced it will offer Amyvid™, a radioactive tracer used in positron emission tomography – computed tomography (PET/CT) imaging, at its Nyack location. Amyvid is the first test that can effectively rule out Alzheimer's disease (AD) in patients who are being evaluated for cognitive impairment.

Every patient with AD has increased levels of beta-amyloid plaque deposits in the brain at autopsy. Amyvid binds to beta-amyloid plaque and allows a PET/CT image to detect their presence. A positive Amyvid scan indicates moderate to frequent beta-amyloid plaques are present. While this amount of beta-amyloid plaque is present in patients with AD, it is also found in patients with other types of neurologic conditions and in older people with normal cognition.

"A negative Amyvid scan provides persuasive evidence AD is not the cause for a patient's observed cognitive decline," said Mark Geller M.D., Chief of Nuclear Medicine at Hudson Valley PET/CT and board certified radiologist. "This imaging technique will allow researchers to design more selective clinical trials for the next generation of treatment options."

Prior to the release of Amyvid PET/CT imaging, physicians had limited tools to definitively diagnose a patient with AD. More than 20 percent of AD cases are currently misdiagnosed. AD is the sixth leading cause of death in the U.S. Among the top 10 causes of death, AD is the only one that cannot be medically cured, prevented or slowed down. Between 2000 and 2008, U.S. AD deaths rose 66 percent.

"While this new diagnostic tool cannot confirm an AD diagnosis, it allows physicians to identify and treat patients for other causes of cognitive impairment if they have a negative Amyvid scan," said Dr. Mark Geller. "Our patients will have a unique opportunity to benefit from the latest development in PET/CT imaging."

About Hudson Valley Radiology Associates
Hudson Valley Radiology Associates (HVRA) is one of the largest imaging providers in Rockland, Westchester and Ulster counties with six convenient outpatient locations. HVRA offers a complete range of imaging services including Digital Mammography, X-Ray, MRI/MRA, CT/CTA, PET/CT, Nuclear Medicine, Ultrasound and DEXA.


'/>"/>
SOURCE Hudson Valley Radiology Associates
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Telemedicine, Teleradiology, and Telemonitoring Look Like Winners in the New Healthcare Economy
2. Analysis of the North American Radiology Image and Information Management Systems Market
3. CentraState and Freehold Radiology Group train physicians from China
4. Veris Associates, Inc. - New Team Member
5. Health Revenue Assurance Associates Hires Valerie Rinkle as Vice President of Revenue Integrity Informatics
6. TSI Healthcare adds Arthritis and Rheumatology Associates of Palm Beach to growing list of Rheumatology Clients
7. Arthritis Associates of South Florida Acquires Access to Patient Health History Faster with Digital Pen Technology from Anoto and NextGen Healthcare
8. Kaiser Permanente Ranks Highest in 2012 J.D. Power and Associates Employer Satisfaction Study for Second Year in a Row
9. Schulman Associates IRB offers oncology-focused review board
10. Sensus Healthcare and Texas Dermatology Associates at Baylor University Medical Center Announce the Formation of the SRT University™ Comprehensive Education Series for Practitioners, Healthcare Professionals, and Patients
11. Cardium to Present at Sachs Associates 2012 Science, Partner, and Investment Forum: Gateway for the Global Life Sciences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2017)... Sept. 18, 2017 EpiVax, Inc. ... bioinformatics and immune engineering, today announced a ... A (H7N9) vaccine. ... seasonal influenza and presents a challenge for ... exposure to be effective. Using state-of-the-art bioinformatics and ...
(Date:9/12/2017)... and NEW YORK , Sept. 12, 2017 ... performance ratings for global supply chains, has published the first annual edition ... CSR performance of more than 20,400 companies evaluated by EcoVadis, based on ... 2015 and 2016. ... EcoVadis Global CSR Risk & Performance Index ...
(Date:9/12/2017)... FRANCISCO , Sept. 12, 2017  ValGenesis ... Management Solutions (VLMS), is pleased to announce the ... a member of its Board of Directors and ... ValGenesis VLMS enables life science companies to manage ... the use of paper in this process. Furthermore, ...
Breaking Medicine Technology:
(Date:10/13/2017)... York, NY (PRWEB) , ... October 13, 2017 , ... ... influential people in business to advocate for action towards gender equality at their inaugural ... views from around the globe, and reached a social audience of over 3 million. ...
(Date:10/13/2017)... ... October 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The ... the most popular and least understood books in the Holy Scriptures, Revelation. The Book ... have baffled scholars for centuries. Many have tossed it off as mere rubbish, but ...
(Date:10/13/2017)... , ... October 13, 2017 , ... ... and Agile Software Development, has been awarded a contract by the Center for ... Agreement (BPA) aims to accelerate the enterprise use of Agile methodologies in a ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... “America On ... Christian identity. “America On The Brink” is the creation of published author, William ... several great-grandchildren. As a WWII veteran, he spent thirty years in the Navy. ...
(Date:10/12/2017)... Francisco, CA (PRWEB) , ... October 12, 2017 ... ... Dr. Cheng, are now treating sleep apnea using cutting-edge Oventus O2Vent ... apnea, a serious sleep disorder characterized by frequent cessation in breathing. Oral appliances ...
Breaking Medicine News(10 mins):